|
TBCEL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.27459999996493E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.50139999952759E-07 |
| Normal-vs-Stage2 |
1.088190E-01 |
| Normal-vs-Stage3 |
2.135600E-03 |
| Normal-vs-Stage4 |
6.387000E-04 |
| Stage1-vs-Stage2 |
2.055200E-01 |
| Stage1-vs-Stage3 |
9.098800E-01 |
| Stage1-vs-Stage4 |
4.929400E-01 |
| Stage2-vs-Stage3 |
3.167400E-01 |
| Stage2-vs-Stage4 |
2.095600E-01 |
| Stage3-vs-Stage4 |
6.219800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50140999999326E-05 |
| Normal-vs-AfricanAmerican |
6.957300E-04 |
| Normal-vs-Asian |
8.232200E-04 |
| Caucasian-vs-AfricanAmerican |
8.243600E-01 |
| Caucasian-vs-Asian |
4.133800E-01 |
| AfricanAmerican-vs-Asian |
3.701200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68619999962871E-07 |
| Normal-vs-Female |
1.067770E-01 |
| Male-vs-Female |
4.101100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.57759999999919E-05 |
| Normal-vs-Extreme_Weight |
5.19249998554017E-09 |
| Normal-vs-Obese |
2.247800E-02 |
| Normal-vs-Extreme_Obese |
2.631700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.731600E-01 |
| Normal_Weight-vs-Obese |
1.035810E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.033600E-01 |
| Extreme_Weight-vs-Obese |
2.499400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.123400E-01 |
| Obese-vs-Extreme_Obese |
6.448800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.496200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.197100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.0146999995797E-07 |
| Normal-vs-Age(81-100Yrs) |
3.06640000002911E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.507400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.841910E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.603540E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.204400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.716100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.937800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.16509999999559E-05 |
| Normal-VS-Type2 PRCC |
1.44489999964748E-07 |
| Normal-VS-KIRP CIMP |
9.267600E-01 |
| Normal-VS-Unclassified PRCC |
3.140200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.984400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.990400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.679770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.415820E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.328000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.532200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31999999997134E-06 |
| Normal-vs-N1 |
2.749600E-02 |
| Normal-vs-N2 |
4.629100E-04 |
| N0-vs-N1 |
2.072000E-01 |
| N0-vs-N2 |
3.408600E-01 |
| N1-vs-N2 |
2.277400E-01 |
|
|
